Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05414994 · ClinicalTrials.gov registry record
Assessment of the Ocular Microbiome in Health and Disease
A clinical trial of Eye Diseases and Microbial Colonization, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05414994 is a study of Eye Diseases and Microbial Colonization that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 500 participants, below the 741,284-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05414994, a study of Eye Diseases and Microbial Colonization, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this application is to illustrate the core constituents of the ocular surface microbiome, describe factors that promote colonization, and assess the ocular microbiome's role in the health of the anterior segment. We will conduct a prospective, observational cohort study, including a longitudinal analysis of the ocular microbiome in adults.
Conditions Studied
Interventions
- OTHER Eye swab
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-09-07 |
| Est. Completion | 2027-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05414994
The ClinicalTrials.gov registry entry for NCT05414994 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 741,284-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Eye Diseases appearing as the primary indexed condition, and to 1 intervention - of which Eye swab is the first listed.
NCT05414994 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05414994 about?
NCT05414994 is a clinical study titled "Assessment of the Ocular Microbiome in Health and Disease". The objective of this application is to illustrate the core constituents of the ocular surface microbiome, describe factors that promote colonization, and assess the ocular microbiome's role in the health of the anterior segment. We will conduct a prospective, observational cohort study, including a...
What is the current status of trial NCT05414994?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-09-07. Estimated completion is 2027-12-30.
What conditions does trial NCT05414994 study?
This clinical trial studies the following conditions: Eye Diseases, Microbial Colonization, Ophthalmopathy.
What interventions are being tested in trial NCT05414994?
The interventions under investigation include: Eye swab (OTHER).
Who is sponsoring clinical trial NCT05414994?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05414994 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
RECRUITING · NA
-
IRIS Registry: Intelligent Research in Sight Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.